CVS Health Outlines Margin Recovery Strategy Amid Upcoming Challenges
CVS Health reported improved momentum across its key segments, including Aetna, pharmacy operations, Oak Street Health, and the balance sheet. Pharmacy growth has returned to mid-single digits after years of decline, while leverage is now in the mid-3-times range. The company emphasized progress on margin recovery for Aetna amid rising medical costs but remains cautious about 2027 Medicare Advantage bids due to uncertainty around Medicaid policies. CVS Health faces several headwinds ahead, including declining revenue from its 340B program and a less robust Caremark selling season. The company plans to support its dividend in the near term and may resume share buybacks by 2026 while considering disciplined acquisitions for growth. Aetna is focusing on cost management through initiatives like prior-authorization reform, provider partnerships, and digital tools. Despite these challenges, executives expressed confidence in their ability to deliver results as they work toward restoring margins and improving cash flow.
Tickers: $CVS
Topics: dividend_policy healthcare insurance M&A pharmacy_operations